No sepsis (N = 300) | Sepsis (N = 75) | |
---|---|---|
Unique patients, count | 271 | 71 |
Age [IQR] | 60.0 [45.0, 69.0] | 65.0 [56.0, 72.0] |
Sex, male count (%) | 159 (53.0%) | 38 (50.7%) |
Days symptoms prior ED visit, days [IQR] | 3.0 [2.0, 5.0] | 2.0 [1.0, 3.0] |
Charlson Comorbidity Index | 4.0 [2.0, 6.0] | 5.0 [4.0, 7.0] |
qSOFA | ||
0 | 235 (78.3%) | 20 (26.7%) |
1 | 60 (20.0%) | 32 (42.7%) |
2 | 5 (1.7%) | 18 (24.0%) |
3 | 0 (0.0%) | 5 (6.7%) |
MEWS (IQR) | 1.0 [0.0, 3.0] | 5.0 [3.0, 6.5] |
Immuno-compromised, count (%) | 114 (38.1%) | 21 (28.0%) |
ED specialty, | ||
Haematology | 52 (17.3%) | 8 (10.7%) |
Internal Medicine | 93 (31.0%) | 33 (44.0%) |
Nephrology | 58 (19.3%) | 10 (13.3%) |
Oncology | 54 (18.0%) | 15 (20.0%) |
Other | 43 (14.3%) | 9 (12.0%) |
Length of stay, days (IQR) | 0.0 [0.0, 4.0] | 7.0 [3.5, 12.5] |
Primary infection noted in discharge letter, count (%) | ||
Cardiovascular | 3 (0.7%) | 4 (5.3%) |
Intra-abdominal | 40 (13.3%) | 6 (8.0%) |
No infection | 26 (8.7%) | 3 (4.0%) |
Other | 21 (7.0%) | 3 (4.0%) |
Respiratory tract infection | 154 (51.3%) | 37 (49.3%) |
Skin Infection | 16 (5.3%) | 4 (5.3%) |
Unknown | 3 (1.0%) | 0 (0.0%) |
Urinary tract infection | 37 (12.3%) | 18 (24.0%) |
Broad spectrum antibiotics, count (%) | 52 (17.3%) | 51 (68.0%) |
ICU admission*, count (%) | 8 (2.7%) | 10 (15.2%) |
In-hospital mortality admission, count (%) | 4 (1.3%) | 11 (14.7%) |